Immune-mediated necrotizing myopathy: an emerging disorder

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Observational analysis highlights symptom onset and treatment strategies in IMNM patients, indicating the importance of early diagnosis.

Overall, 81.3% of patients previously received statin therapy, suggesting a possible link to disease onset.
Notably, the only specific autoantibodies detected were anti-HMGCR antibodies in 81.3% of cases, aiding diagnosis.
In this cohort, 68.8% of patients were diagnosed within six months of symptom onset, highlighting the need for timely identification.
The treatment strategy often combines corticosteroids with other immunosuppressive drugs, reflecting treatment complexity.

Sanchez et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

Observational analysis highlights symptom onset and treatment strategies in IMNM patients, indicating the importance of early diagnosis.

Overall, 81.3% of patients previously received statin therapy, suggesting a possible link to disease onset.
Notably, the only specific autoantibodies detected were anti-HMGCR antibodies in 81.3% of cases, aiding diagnosis.
In this cohort, 68.8% of patients were diagnosed within six months of symptom onset, highlighting the need for timely identification.
The treatment strategy often combines corticosteroids with other immunosuppressive drugs, reflecting treatment complexity.

Sanchez et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark